{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:31Z","timestamp":1753890751719,"version":"3.41.2"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pituitary adenoma (PA) is the third most common central nervous system tumor originating from the anterior pituitary, but its pathogenesis remains unclear. The Wnt signaling pathway is a conserved pathway involved in cell proliferation, Self-renewal of stem cells, and cell differentiation. It is related to the occurrence of various tumors, including PA. This article reviews the latest developments in Wnt pathway inhibitors and pathway-targeted drugs. It discusses the possibility of combining Wnt pathway inhibitors with immunotherapy to provide a theoretical basis for the combined treatment of PA.<\/jats:p>","DOI":"10.3389\/fendo.2023.1216817","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:24:48Z","timestamp":1694726688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Research progress on the role of the Wnt signaling pathway in pituitary adenoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Wencai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121884","article-title":"Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up","volume":"11","author":"Kessel","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J Neurooncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10194-008-0084-0","article-title":"Headache associated with pituitary tumors","volume":"10","author":"Gondim","year":"2009","journal-title":"J Headache Pain"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2015.301","article-title":"Sellar masses: an epidemiological study","volume":"43","author":"Al-Dahmani","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114705","article-title":"Clinically nonfunctioning pituitary tumors are monoclonal in origin","volume":"86","author":"Alexander","year":"1990","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","article-title":"The pathogenesis of pituitary tumors","volume":"4","author":"Asa","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signaling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.082","article-title":"Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer","volume":"110","author":"Cheng","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.ctdb.2022.02.008","article-title":"Different strategies by distinct Wnt-signaling pathways in activating a nuclear transcriptional response","volume":"149","author":"Vuong","year":"2022","journal-title":"Curr Top Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2007.71","article-title":"Evaluating the role of Wnt signal transduction in promoting the development of the heart","volume":"7","author":"Eisenberg","year":"2007","journal-title":"Sci World J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.05.023","article-title":"Wnt signaling in atherosclerosis","volume":"763","author":"Matthijs Blankesteijn","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030483","article-title":"Progress of wnt signaling pathway in osteoporosis","volume":"13","author":"Gao","year":"2023","journal-title":"Biomolecules"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-015-2333-2","article-title":"lncRNA DANCR suppresses odontoblast-like differentiation of human dental pulp cells by inhibiting wnt\/\u03b2-catenin pathway","volume":"364","author":"Chen","year":"2016","journal-title":"Cell Tissue Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.24329","article-title":"Role of DKK4 in tumorigenesis and tumor progression","volume":"14","author":"Cai","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1038\/srep04493","article-title":"Noncanonical Wnt5a enhances Wnt\/beta-catenin signaling during osteoblastogenesis","volume":"4","author":"Okamoto","year":"2014","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204989200","article-title":"A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta -catenin-dependent signaling","volume":"277","author":"Holmen","year":"2002","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2741\/1307","article-title":"The WNT\/calcium pathway: biochemical mediators, tools and future requirements","volume":"9","author":"K\u00fchl","year":"2004","journal-title":"Front Biosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085259","article-title":"Wnt signaling, Ca2+, and cyclic GMP: visualizing Frizzled functions","volume":"300","author":"Wang","year":"2003","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(03)00266-1","article-title":"A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling","volume":"5","author":"Veeman","year":"2003","journal-title":"Dev Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2021.10.002","article-title":"Vertebrate Wnt5a - At the crossroads of cellular signaling","volume":"125","author":"Rogers","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2005.06.022","article-title":"Wnt and calcium signaling: beta-catenin-independent pathways","volume":"38","author":"Kohn","year":"2005","journal-title":"Cell Calcium"},{"key":"B24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1083\/jcb.200303158","article-title":"Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation","volume":"162","author":"Topol","year":"2003","journal-title":"J Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.68960","article-title":"PROX1 promotes breast cancer invasion and metastasis through WNT\/\u03b2-catenin pathway via interacting with hnRNPK","volume":"18","author":"Zhu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144852","article-title":"WNT signaling in melanoma","volume":"21","author":"Gajos-Michniewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B27","article-title":"Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett's associated esophageal adenocarcinoma","volume":"9","author":"Lyros","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1121787","article-title":"Non-canonical Wnt\/Ca2+ signaling is essential to promote self-renewal and proliferation in colon cancer stem cells","volume":"13","author":"Sarabia-Sanchez","year":"2023","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0884","article-title":"Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses","volume":"65","author":"Moreno","year":"2005","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.078642","article-title":"Wnt signaling in estrogen-induced lactotroph proliferation","volume":"124","author":"Giles","year":"2011","journal-title":"J Cell Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.04.034","article-title":"Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion","volume":"21","author":"Li","year":"2014","journal-title":"J Clin Neurosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00085-X","article-title":"Differential expression of Wnt genes, b-catenin and E-cadherin in human brain tumors","volume":"83","author":"Hownga","year":"2002","journal-title":"Cancer Letters"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.2862","article-title":"\u03b2-catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression","volume":"46","author":"Zhao","year":"2015","journal-title":"Int J Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-012-9197-8","article-title":"Expression and clinical significance of Wnt players and survivin in pituitary tumours","volume":"23","author":"Formosa","year":"2012","journal-title":"Endocr Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6169","article-title":"Increased beta\u2212catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach","volume":"15","author":"Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1216","article-title":"Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells","volume":"152","author":"Acunzo","year":"2011","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28060","article-title":"Pituitary homeobox 2 (PITX2) protects renal cancer cell lines against doxorubicin toxicity by transcriptional activation of the multidrug transporter ABCB1","volume":"133","author":"Lee","year":"2013","journal-title":"Int J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03105-9","article-title":"A systematic review of molecular alterations in invasive non-functioning pituitary adenoma","volume":"77","author":"Hosseinkhan","year":"2022","journal-title":"Endocrine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10555-017-9659-z","article-title":"Crosstalk signaling in targeted melanoma therapy","volume":"36","author":"Meierjohann","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10311","article-title":"SOX2 mediates crosstalk between Sonic Hedgehog and the Wnt\/beta-catenin signaling pathway to promote proliferation of pituitary adenoma cells","volume":"18","author":"Tang","year":"2019","journal-title":"Oncol Lett"},{"key":"B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mce.2010.02.039","article-title":"Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach","volume":"326","author":"Elston","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1759720X12466608","article-title":"Wnt signaling in bone formation and its therapeutic potential for bone diseases","volume":"5","author":"Kim","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027690","article-title":"A cytokine-like protein dickkopf-related protein 3 is atheroprotective","volume":"136","author":"Yu","year":"2017","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"pe22","DOI":"10.1126\/scisignal.2003028","article-title":"The structural basis of DKK-mediated inhibition of Wnt\/LRP signaling","volume":"5","author":"Bao","year":"2012","journal-title":"Sci Signal"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.13636","article-title":"SARPs: a family of secreted apoptosis-related proteins","volume":"94","author":"Melkonyan","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.2859","article-title":"A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors","volume":"94","author":"Rattner","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0579-4","article-title":"Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma","volume":"18","author":"Wu","year":"2015","journal-title":"Pituitary"},{"key":"B48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/ol.2016.4560","article-title":"Low expression of secreted frizzled-related protein 2 and nuclear accumulation of beta-catenin in aggressive nonfunctioning pituitary adenoma","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol Lett"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4355","article-title":"Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling","volume":"52","author":"Ren","year":"2018","journal-title":"Int J Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123496","article-title":"Wnt inhibitory factor 1 binds to and inhibits the activity of sonic hedgehog","volume":"10","author":"Kerekes","year":"2021","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1344","article-title":"Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt\/beta-catenin signaling pathway","volume":"12","author":"Urakami","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0617-08.2008","article-title":"Zebrafish olfactomedin 1 regulates retinal axon elongation in vivo and is a modulator of Wnt signaling pathway","volume":"28","author":"Nakaya","year":"2008","journal-title":"J Neurosci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2018.03.005","article-title":"Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas","volume":"474","author":"Song","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.06.154","article-title":"Association of TGF-beta1 and WIF1 expression with 36 paired primary\/recurrent nonfunctioning pituitary adenomas: A high-throughput tissue microarrays immunohistochemical study","volume":"119","author":"Zhu","year":"2018","journal-title":"World Neurosurg"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10555","article-title":"Impact of SLC20A1 on the Wnt\/beta\u2212catenin signaling pathway in somatotroph adenomas","volume":"20","author":"Li","year":"2019","journal-title":"Mol Med Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12967-019-1915-2","article-title":"Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model","volume":"17","author":"Cheng","year":"2019","journal-title":"J Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02544","article-title":"MiR-137's tumor suppression on prolactinomas by targeting MITF and modulating wnt signaling pathway","volume":"104","author":"Lei","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23913","article-title":"Dkk3, downregulated in cervical cancer, functions as a negative regulator of \u03b2-catenin","volume":"124","author":"Lee","year":"2009","journal-title":"Int J Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667480","article-title":"Hematopoietic wnts modulate endochondral ossification during fracture healing","volume":"12","author":"Chua","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0772","article-title":"Effects of active acromegaly on bone mRNA and microRNA expression patterns","volume":"178","author":"Belaya","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4241-7","article-title":"Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans","volume":"29","author":"Belaya","year":"2018","journal-title":"Osteoporos Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1694-y","article-title":"FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt\/\u03b2-catenin signaling pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/09168451.2019.1591260","article-title":"MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt\/beta-catenin pathway by negative regulation of Smad7","volume":"83","author":"Shen","year":"2019","journal-title":"Biosci Biotechnol Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.917110","article-title":"Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) enhances proliferation, migration, and epithelial-mesenchymal transition (EMT) of pituitary adenoma cells by activating \u03b2-catenin, c-myc, and cyclin D1 expression","volume":"25","author":"Zhang","year":"2019","journal-title":"Med Sci Monit"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","article-title":"CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/beta-catenin pathway","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.04.018","article-title":"Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development","volume":"161","author":"Du","year":"2020","journal-title":"Brain Res Bull"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147676","article-title":"Characterization of adrenal miRNA-based dysregulations in cushing's syndrome","volume":"23","author":"Vetrivel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/a-1066-4592","article-title":"Updates in the medical treatment of pituitary adenomas","volume":"52","author":"Gheorghiu","year":"2019","journal-title":"Hormone Metab Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-5374.2012.04.008","article-title":"Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cells","volume":"7","author":"Bai","year":"2012","journal-title":"Neural Regener Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.07.008","article-title":"Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas","volume":"20","author":"Bai","year":"2013","journal-title":"J Clin Neurosci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1351-8","article-title":"Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models","volume":"116","author":"Cao","year":"2014","journal-title":"J Neurooncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-013-1571-8","article-title":"The Wnt\/beta-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells","volume":"35","author":"Cao","year":"2014","journal-title":"Tumour Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1053\/j.seminoncol.2003.08.003","article-title":"Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor","volume":"30","author":"Jones","year":"2003","journal-title":"Semin Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000532","article-title":"A rare case of fulvestrant-associated jaundice and hepatotoxicity","volume":"26","author":"Dziamski","year":"2019","journal-title":"Am J Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004143","article-title":"Oral cedazuridine\/decitabine for MDS and CMML: a phase 2 pharmacokinetic\/pharmacodynamic randomized crossover study","volume":"136","author":"Garcia-Manero","year":"2020","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30210-6","article-title":"10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial","volume":"7","author":"DiNardo","year":"2020","journal-title":"Lancet Haematol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5618","article-title":"NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation","volume":"13","author":"Lai","year":"2017","journal-title":"Oncol Lett"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1172\/JCI144618","article-title":"Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2","volume":"130","author":"Wang","year":"2020","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7150\/jca.52937","article-title":"NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas","volume":"12","author":"Jian","year":"2021","journal-title":"J Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01238-8","article-title":"Pituitary acting drugs: cabergoline and pasireotide","volume":"25","author":"Gadelha","year":"2022","journal-title":"Pituitary"},{"key":"B81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/TUB-211500","article-title":"beta-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by temozolomide in prolactin secreting tumor models","volume":"44","author":"Demarchi","year":"2022","journal-title":"Tumour Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.870172","article-title":"Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the beta-Catenin and alpha-SMA Expression","volume":"13","author":"Demarchi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab240","article-title":"Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system Malignancies","volume":"24","author":"Park","year":"2022","journal-title":"Neuro Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1159\/000353752","article-title":"Temozolomide-related hematologic toxicity","volume":"36","author":"Scaringi","year":"2013","journal-title":"Onkologie"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-022-04109-1","article-title":"Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy","volume":"159","author":"Climans","year":"2022","journal-title":"J Neurooncol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"160","DOI":"10.25259\/IJDVL_754_2021","article-title":"Temozolomide-induced drug rash with eosinophilia and systemic symptoms syndrome","volume":"89","author":"Mehta","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041990","article-title":"Renoprotective effects of tanshinone IIA: A literature review","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/10286020.2016.1217520","article-title":"Cassane-type diterpenes from Caesalpinia minax induce apoptosis in pituitary adenoma: structure-activity relationship, ER stress, and Wnt\/beta-catenin pathways","volume":"19","author":"Li","year":"2017","journal-title":"J Asian Nat Prod Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7325","article-title":"Tanshinone IIA induces apoptosis via inhibition of Wnt\/beta\u2212catenin\/MGMT signaling in AtT\u221220 cells","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1095943","article-title":"gC1qR: A new target for cancer immunotherapy","volume":"14","author":"Lei","year":"2023","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-023-01301-y","article-title":"Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis","author":"Ben-Shlomo","year":"2023","journal-title":"Pituitary"},{"key":"B92","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/endrev\/bnac024","article-title":"Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas","volume":"44","author":"Ilie","year":"2023","journal-title":"Endocr Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100852","article-title":"The tumour microenvironment of pituitary neuroendocrine tumours","volume":"58","author":"Marques","year":"2020","journal-title":"Front Neuroendocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1216817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:24:54Z","timestamp":1694726694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1216817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":93,"alternative-id":["10.3389\/fendo.2023.1216817"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1216817","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"article-number":"1216817"}}